TY - JOUR
T1 - Isomeric iodinated analogs of nimesulide
T2 - Synthesis, physicochemical characterization, cyclooxygenase-2 inhibitory activity, and transport across Caco-2 cells
AU - Yamamoto, Yumi
AU - Arai, Jun
AU - Hisa, Takuya
AU - Saito, Yohei
AU - Mukai, Takahiro
AU - Ohshima, Takashi
AU - Maeda, Minoru
AU - Yamamoto, Fumihiko
N1 - Funding Information:
This research was partially supported by a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (Nos. 24791331 , 26861015 ). The authors acknowledge Kaori Morimoto Ph.D., Tohoku Medical and Pharmaceutical University, for valuable discussions on the transport assay. We greatly appreciate Ms. Miho Takeda for her technical assistance.
Publisher Copyright:
© 2016 Elsevier Ltd
PY - 2016
Y1 - 2016
N2 - Isomeric iodinated derivatives of nimesulide, with an iodine substituent on the phenoxy ring, were prepared with the aim of identifying potential candidate compounds for the development of imaging agents targeting cyclooxygenase-2 (COX-2) in the brain. Both the experimental log P7.4and pKavalues for these iodinated analogs were in the acceptable range for passive brain penetration. The para-iodo-substituted analog was a more potent and selective COX-2 inhibitor than nimesulide, with a potency that was comparable to the reference drug, celecoxib. Iodination at the ortho- or meta-position of the phenoxy ring was associated with a substantial loss of COX-2 inhibitory activity. Transport studies across Caco-2 cell monolayers in the presence and absence of a P-glycoprotein (P-gp) inhibitor, verapamil, indicated that the para-iodo-substituted analog was not a P-gp transport substrate; this feature is a prerequisite for potential in vivo brain imaging compounds. The para-iodo-substituted analog of nimesulide appears to be an attractive candidate for the development of radioiodine-labeled tracers for in vivo brain imaging of COX-2 levels.
AB - Isomeric iodinated derivatives of nimesulide, with an iodine substituent on the phenoxy ring, were prepared with the aim of identifying potential candidate compounds for the development of imaging agents targeting cyclooxygenase-2 (COX-2) in the brain. Both the experimental log P7.4and pKavalues for these iodinated analogs were in the acceptable range for passive brain penetration. The para-iodo-substituted analog was a more potent and selective COX-2 inhibitor than nimesulide, with a potency that was comparable to the reference drug, celecoxib. Iodination at the ortho- or meta-position of the phenoxy ring was associated with a substantial loss of COX-2 inhibitory activity. Transport studies across Caco-2 cell monolayers in the presence and absence of a P-glycoprotein (P-gp) inhibitor, verapamil, indicated that the para-iodo-substituted analog was not a P-gp transport substrate; this feature is a prerequisite for potential in vivo brain imaging compounds. The para-iodo-substituted analog of nimesulide appears to be an attractive candidate for the development of radioiodine-labeled tracers for in vivo brain imaging of COX-2 levels.
UR - http://www.scopus.com/inward/record.url?scp=84978234782&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978234782&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2016.06.015
DO - 10.1016/j.bmc.2016.06.015
M3 - Article
C2 - 27325447
AN - SCOPUS:84978234782
SN - 0968-0896
VL - 24
SP - 3727
EP - 3733
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 16
ER -